piperacillin has been researched along with Shock, Septic in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 15 (42.86) | 29.6817 |
| 2010's | 15 (42.86) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, K; Fukuda, T; Imaizumi, K; Isogami, H; Kamo, N; Sugeno, M; Yamaguchi, A; Yasuda, S | 1 |
| Delattre, IK; Dugernier, T; Hites, M; Jacobs, F; Laterre, PF; Spapen, H; Taccone, FS; Wallemacq, PE | 1 |
| Bernard, S; Lee, K; Pakyz, A; Stevens, M; Vaughan, D | 1 |
| Calvo, G; Llauradó-Serra, M; Martín-Loeches, I; Pontes, C; Soy, D; Ulldemolins, M; Vaquer, S | 1 |
| Brock, B; Gjedsted, J; Hardlei, TF; Juul, RV; Kreilgaard, M; Öbrink-Hansen, K; Storgaard, M; Thomsen, MK | 1 |
| Herodes, K; Karjagin, J; Kern, H; Kipper, K; Metsvaht, T; Oselin, K; Starkopf, J; Tamme, K; Tasa, T | 1 |
| Deis, AS; Simpson, SQ; Whiles, BB | 1 |
| Breilh, D; Jaber, S; Jean-Pierre, H; Jung, B; Legeron, R; Mahul, M; Molinari, N; Signe, J; Uhlemann, AC | 1 |
| Barie, PS; Cayci, C; Eachempati, SR; Fusco, D; Goldstein, MJ; Huston, JM; Kapur, S; Mathew, M; Rodney, JR; Shou, J | 1 |
| Baudrand, H; Devouassoux, G; Freymond, N; Marcu, M; Mbatchou Ngahane, BH; Pacheco, Y | 1 |
| Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
| Foley, RJ; Kannan, S; Kourelis, T | 1 |
| Enkhbaatar, P; Maybauer, DM; Maybauer, MO; Nakano, Y; Traber, DL | 1 |
| De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X | 1 |
| Cotton, F; De Backer, D; Jacobs, F; Macours, P; Seyler, L; Taccone, FS; Vincent, JL | 1 |
| Gomi, H; Miura, Y; Morisawa, Y; Sugano, K; Yokota, K | 1 |
| Chen, YM; Huang, CC; Kuo, CC; Tsai, CH; Yang, FJ | 1 |
| Bond, CM; Bullard, MJ; Djogovic, D; Meurer, DP; Rowe, BH; Villa-Roel, C | 1 |
| Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
| Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Riva, A; Saba, V; Scalise, G; Silvestri, C | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Sisti, V | 1 |
| Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Kamysz, W; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Viticchi, C; łLukasiak, J | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Lukasiak, J; Mocchegiani, F; Naldoski, P; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Sisti, V | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC | 1 |
| Bergnach, C; Cirioni, O; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Skerlavaj, B; Zanetti, M | 1 |
| Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C | 1 |
| Kinzer, S; Maier, W; Ridder, GJ | 1 |
| Clapson, P; Debien, B; Leclerc, T; Lenoir, B; Perez, JP | 1 |
| Abbruzzetti, A; Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Thieme, H; Tunn, UW | 1 |
| Althoff, PH; Fischer, M; Stern, M | 1 |
| Barale, F; Blasco, G; Boillot, A; Capellier, G; Cornette, C; Guinchard, C; Jacques, T | 1 |
| Brunner, M; Eichler, HG; Frossard, M; Joukhadar, C; Klein, N; Mayer, BX; Müller, M; Siostrzonek, P | 1 |
| Cirioni, O; Del Prete, MS; Fineo, A; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G | 1 |
1 review(s) available for piperacillin and Shock, Septic
| Article | Year |
|---|---|
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Critical Illness; Humans; Meropenem; Piperacillin; Renal Replacement Therapy; Shock, Septic; Thienamycins | 2014 |
34 other study(ies) available for piperacillin and Shock, Septic
| Article | Year |
|---|---|
Maternal septic shock due to Acinetobacter lwoffii infection:a case report.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Cesarean Section; Female; Humans; Infant, Newborn; Middle Aged; Piperacillin; Pneumonia; Pregnancy; Shock, Septic | 2023 |
What is the optimal loading dose of broad-spectrum β-lactam antibiotics in septic patients? Results from pharmacokinetic simulation modelling.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Computer Simulation; Humans; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Shock, Septic | 2020 |
Adequacy of empiric gram-negative coverage for septic patients at an academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Humans; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Shock, Septic; Virginia; Young Adult | 2019 |
Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?
Topics: Aged; Anti-Bacterial Agents; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Shock, Septic; Tazobactam | 2015 |
Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam during high volume haemodiafiltration in patients with septic shock.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Female; Hemodiafiltration; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Shock, Septic | 2016 |
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Comorbidity; Disease Progression; Female; Hospital Mortality; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Time Factors; Time-to-Treatment; Vasoconstrictor Agents | 2017 |
Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Mass Index; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Shock, Septic | 2017 |
Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
Topics: Aged, 80 and over; Albendazole; Animals; Anti-Infective Agents; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Ivermectin; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Protein C; Recombinant Proteins; Respiratory Distress Syndrome; Shock, Septic; Strongyloides stercoralis; Strongyloidiasis; Superinfection; Tazobactam; Treatment Outcome | 2009 |
[Lung abscess due to community acquired Klebsiella pneumonia].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Community-Acquired Infections; Comorbidity; Diabetes Mellitus; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lung Abscess; Male; Middle Aged; Piperacillin; Radiography, Thoracic; Shock, Septic; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
An unusual case of septic shock in a geriatric patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antidiuretic Agents; Capnocytophaga; Female; Fluid Therapy; Gram-Negative Bacterial Infections; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Risk Factors; Shock, Septic; Tazobactam; Vancomycin; Vasopressins | 2010 |
A novel antibiotic based long-term model of ovine smoke inhalation injury and septic shock.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Disease Models, Animal; Female; Nitric Oxide; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Sheep, Domestic; Shock, Septic; Smoke Inhalation Injury; Time Factors | 2010 |
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins | 2010 |
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Female; Humans; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Prospective Studies; Pseudomonas aeruginosa; Renal Replacement Therapy; Shock, Septic; Thienamycins | 2011 |
Cholangitis with septic shock caused by Raoultella planticola.
Topics: Aged; Anti-Bacterial Agents; Cholangitis; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunocompromised Host; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Shock, Septic; Treatment Outcome | 2012 |
Bubbles in the urinary bladder.
Topics: Anti-Bacterial Agents; Cystitis; Female; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Shock, Septic; Tazobactam; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Diseases | 2012 |
Pilot study comparing sepsis management with and without electronic clinical practice guidelines in an academic emergency department.
Topics: Aged; Anti-Bacterial Agents; Clinical Protocols; Disease Management; Emergency Service, Hospital; Female; Hospitals, Teaching; Humans; Internet; Male; Middle Aged; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sepsis; Shock, Septic; Treatment Outcome | 2013 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Antiendotoxin activity of antimicrobial peptides and glycopeptides.
Topics: Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Male; Penicillins; Piperacillin; Proteins; Random Allocation; Rats; Rats, Wistar; Shock, Septic; Teicoplanin; Vancomycin | 2003 |
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Synergism; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Insect Proteins; Lipopolysaccharides; Male; Piperacillin; Rats; Rats, Wistar; Shock, Septic | 2004 |
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock.
Topics: Animals; Antimicrobial Cationic Peptides; Cecum; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Ligation; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peptides; Peritonitis; Piperacillin; Proteins; Punctures; Rats; Rats, Wistar; Shock, Septic | 2003 |
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Topics: Abdomen; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Colony Count, Microbial; Endotoxins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Penicillins; Peritonitis; Piperacillin; Rats; Rats, Wistar; Sepsis; Shock, Septic; Tumor Necrosis Factor-alpha | 2004 |
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Limulus Test; Lipopolysaccharides; Male; Piperacillin; Polymyxin B; Rats; Rats, Wistar; Shock, Septic; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors | 2006 |
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Cecum; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Imipenem; Injections, Intraperitoneal; Male; Nitrites; Piperacillin; Polymyxin B; Random Allocation; Rats; Rats, Wistar; Serotyping; Shock, Septic; Tumor Necrosis Factor-alpha | 2006 |
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic | 2006 |
[Peritonsillar abscess: a life threatening disease--diagnostic and therapeutic aspects].
Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Male; Mediastinitis; Multiple Organ Failure; Penicillanic Acid; Peritonsillar Abscess; Piperacillin; Radiography, Thoracic; Shock, Septic; Tazobactam; Tobramycin; Tomography, X-Ray Computed; Tonsillectomy | 2007 |
[Treatment of a septic shock due to multiresistant Acinetobacter baumannii with tigecycline in combination].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Minocycline; Penicillanic Acid; Piperacillin; Shock, Septic; Tazobactam; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Tazobactam; Treatment Outcome | 2008 |
Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillin.
Topics: Adult; Bacterial Infections; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Penicillins; Piperacillin; Pseudomonas Infections; Shock, Septic; Urinary Tract Infections | 1982 |
[Severe infection by methicillin-resistant staphylococci after insertion of PEG].
Topics: Aged; Aged, 80 and over; Enteral Nutrition; Female; Gastrostomy; Gentamicins; Humans; Injections, Intravenous; Methicillin Resistance; Metronidazole; Piperacillin; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
Topics: Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Critical Illness; Dialysis Solutions; Half-Life; Hemofiltration; Humans; Infusions, Intravenous; Liver Failure; Middle Aged; Multiple Organ Failure; Penicillins; Piperacillin; Prospective Studies; Renal Insufficiency; Shock, Cardiogenic; Shock, Septic | 1998 |
Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock.
Topics: Adipose Tissue; Aged; Anti-Bacterial Agents; Case-Control Studies; Chromatography, High Pressure Liquid; Drug Delivery Systems; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Microdialysis; Middle Aged; Muscle, Skeletal; Piperacillin; Practice Guidelines as Topic; Prospective Studies; Shock, Septic; Time Factors; Tissue Distribution; Treatment Failure | 2001 |
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Infusions, Parenteral; Magainins; Male; Microbial Sensitivity Tests; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Treatment Outcome; Xenopus Proteins | 2002 |